feed,title,long_url,short_url
MedRxiv,"Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12-17 year-old adolescents",https://medrxiv.org/cgi/content/short/2023.02.22.23286317v1?rss=1,https://da.gd/Cvrh
MedRxiv,Safety of the NVX-CoV2373 COVID-19 Vaccine in Randomized Placebo-Controlled Clinical Trials,https://medrxiv.org/cgi/content/short/2023.02.24.23285601v1?rss=1,https://da.gd/q9xB9
